Skip to main content

West Pharmaceutical Services company profile

  • WST · NYSE
  • Medical devices
  • Health Care Supplies
  • S&P 500
$416.42+1.24%Close 13 Nov 2026

About West Pharmaceutical Services

West Pharmaceutical Services designs and manufactures containment and delivery systems for injectable drugs and healthcare products. Its Proprietary Products segment offers elastomer and primary containment components such as stoppers, seals, syringe and cartridge components, vials, plungers, drug delivery and self-injection devices, integrated systems and analytical lab services, primarily for biologic, generic and pharmaceutical drug customers. Its Contract-Manufactured Products segment designs, manufactures and assembles complex devices and customer-owned components for pharmaceutical, diagnostic and medical device customers. The company has manufacturing facilities in North and South America, Europe and Asia, and sells through its own sales force and distribution network. Sales outside the U.S. accounted for 56.7% of consolidated net sales in 2025.

A summary of the business section of the company's latest annual report, filed 17 Feb 2026.

Company facts

TickerWST · NYSE
SectorMedical devices
IndustryHealth Care Supplies
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK105770
Latest annual report10-K, filed 17 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Douglas A. MichelsDirector44.6K · < 1%Grant or award, 4 May 2026
Thomas W. HofmannDirector43.7K · < 1%Grant or award, 6 May 2025
Mark A. ButhmanDirector43.5K · < 1%Grant or award, 4 May 2026
William F. FeeheryDirector30.7K · < 1%Grant or award, 4 May 2026
Myla P. Lai-GoldmanDirector18.6K · < 1%Grant or award, 4 May 2026
Robert W. McMahonSVP & Chief Financial Officer14.6K · < 1%Option exercise, 11 Aug 2026
Paolo PucciDirector10.0K · < 1%Grant or award, 4 May 2026
Deborah L. V. KellerDirector9.7K · < 1%Grant or award, 4 May 2026
Robert F. FrielDirector3.6K · < 1%Grant or award, 4 May 2026
Molly E. JosephDirector3.6K · < 1%Grant or award, 4 May 2026
Shane A. CampbellSVP, Proprietary Segment3.1K · < 1%Shares withheld for tax, 12 May 2026
Stephen H. LockhartDirector2.7K · < 1%Grant or award, 4 May 2026
Janet B. HaugenDirector456 · < 1%Grant or award, 4 May 2026
Annette F. FavoriteSr. VP & Chief HR Officer—Sale under a 10b5-1 plan, 15 Sep 2026
Winters ChadVP, Chief Accounting Officer—Open-market sale, 27 Apr 2026
Poussot Rodolphe JeanSVP, Strategy & Corporate Dev—Shares withheld for tax, 20 Feb 2026
Witherspoon CharlesVP & Treasurer—Shares withheld for tax, 20 Feb 2026
Eric M. GreenPresident, CEO and Board Chair · Director—Option exercise, 18 Feb 2026
Bernard J. BirkettSr VP, Chief Financial Officer—Shares withheld for tax, 18 Feb 2025
Kimberly B. MacKaySVP, GC & Corporate Secretary—Shares withheld for tax, 18 Feb 2025

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

WST in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.